Skip to Main Content
Center for Cancer ResearchCCR Home | About CCR | CCR Intranet

Cell & Molecular Biology Section

Immunology Section
Selected Recent Publications

1. Merchant MS, Geller J, Baird K, Chou A, Galli S, Bernstein D, Charles A, Long L, Amoako M, Rhee EH, Price A, Wexler LH, Meyers PA, Widemann BC, Tsokos M, Mackall CL, Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors. Journal of Clinical Oncology, 2012, In Press.
2. Baird K, Fry TJ, Steinberg SM, Bishop MR, Fowler DH, Delbrook CP, Humphrey JL, Rager A, Richards K, Wayne AS, Mackall CL, Reduced intensity allogeneic stem cell transplantation in children and young adults with ultra high-risk pediatric sarcomas, Bio Blood Marrow Transplant, 2012:18:698-707.
3. Lee DW, Barrett D, Mackall C, Orentas R, Grupp SA. The Future is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer, Clinical Cancer Research, 2012, 18:2780-90.
4. Lundstrom W, Fewkes NM, Mackall CL, IL-7 in Human Health and Disease, Seminars in Immunology, 2012, 24:218-224.
5. Orentas RJ, Lee DW, Mackall CL. Immunotherapy targets in pediatric cancer, Frontiers in Pediatric Oncology, 2012, 2:3
6. Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application, Nature Reviews Immunology, 2011, 11:330-342.
7. Mackall CL, In search of targeted therapies for childhood cancer, Frontiers in Pediatric Oncology, 2011, 1:18
8. Zhang, Cui Y, Voong N, Sabatino M, Stroncek DF, and Morisot S, Civin CI, Wayne AS, Levine BL, Mackall CL, Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells, Journal of Immunotherapy, 2011, 34:187-195.
9. Robbins PF, Morgan RA, Feldman SA, Yang JC, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CR, Levy CL, Li YF, El-Gamil M, Schwarz SL, Laurencot C and Rosenberg SA, Tumor regression in patients with metastatic synovial sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1, Journal of Clinical Oncology, 2011, 29:917-924.
10. Meadors JL, Cui Y, Chen QR, Song YK, Khan J, Merlino G, Tsokos M, Orentas RJ and Mackall CL, Murine Rhabdomyosarcoma is Immunogenic and Responsive to T cell based Immunotherapy, 2011 57:921-929.
11. Du X, Xiang L, Mackall C, Pastan I, Killing of resistant cancer cells with low Bak by a combination of an antimesothelin immunotoxin and a TRAIL receptor 2 agonist antibody, Clinical Cancer Research, 2011 17:5926-34.
12. Sportès C, Babb RR, Krumlauf MC, Hakim FT, Chow CK, Brown MR, Fleisher TA, Noel, P, Maric I, Stetler-Stevenson M, Engels J, Buffet R, Morre M, Amato RJ, Pecora A, Mackall CL and Gress RE, Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy, 2010, Clinical Cancer Research, 16:727-735.
13. Fewkes NM, Krauss AC, Guimond M, Meadors JL, Dobre S, Mackall CL. Pharmacologic modulation of niche accessibility via tyrosine kinase inhibition enhances marrow and thymic engraftment following hematopoietic stem cell transplantation. 2010, Blood, 115:4120-4129.
14. Guimond MS, Veenstra RG, Grindler DJ, Zhang H, Cui Y, Murphy RD, Kim SY, Na R, Henninghausen L, Kurtulus S, Erman B, Matzinger P, Merchant MS, Mackall CL, IL-7 Signaling on IL-7RDCs Regulates the Naïve CD4 Niche Controlling Homeostatic Peripheral Expansion, 2009, Nature Immunology, 10:149-157.
**NCI Press Release**
15. Cui Y, Zhang H, Meadors J, Poon R, Guimond M, Mackall CL, Harnessing the Physiology of Lymphopenia to Support Adoptive Immunotherapy in Lymphoreplete Hosts, 2009, Blood, 114:3831-40.
16. Fox E, Widemann BC, Hawkins D, Jayaprakash N, Dagher R, Aikin AA, Bernstein D, Long L, Oglesby C, Moxness M, Green J, Mackall C, Helman L, Steinberg SM, Balis FM, Randomized trial and pharmacokinetic study of pegfilgrastim vs. filgrastim after dose-intensive chemotherapy in children and young adults with newly diagnosed sarcomas. 2009, Clinical Cancer Research, 15:7361-67.

Dashed Line

return to the top

This Page Last Reviewed on February 26, 2013

About CCR | Clinical Trials | Research | Employment | Initiatives | News | Events | Site Privacy Policy | Accessibility

A Service of the National Cancer Institute

Department of Health and Human Services National Institutes of Health (NIH) USA Gov